Hamid Daaboul

Senior Medical Oncologist with over 20 years of international experience in clinical oncology, translational cancer research, and academic medicine. PhD-trained researcher with expertise in molecular oncology, anticancer drug development, and targeted pathway inhibition (MAPK/ERK and PI3K/AKT). Track record of peer-reviewed publications in high-impact oncology journals, participation in Phase II clinical trials, and academic editorial leadership.

Experienced in multidisciplinary oncology care, postgraduate teaching, and oncology service development in tertiary hospital settings. Seeking a Consultant Medical Oncologist position within a university-affiliated or research-active academic institution.

Resident Consultant Oncologist at Aga Khan Hospital (2023-05 – Present)

Provide comprehensive oncology care across inpatient and outpatient services. Manage complex solid tumors and hematologic malignancies. Active member of multidisciplinary tumor board. Supervise systemic therapies including chemotherapy, immunotherapy, and targeted agents. Mentor oncology nursing staff and junior clinicians.

• Contributed to institutional recognition as a Cancer Management Centre by the National Cancer Institute of Kenya
• Developed structured oncology nursing education programs
• Delivered institutional CME lectures and community cancer awareness initiatives

Head of Department of Oncology at Haroun Hospital, Beirut, Lebanon (2010-02 – 2016-12)

Led oncology department development within a tertiary hospital.

• Standardized chemotherapy protocols and admission documentation
• Implemented cytotoxic drug safety systems
• Secured ISO Accreditation (Grade A, Score 14/15)
• Oversaw installation of laminar flow hood for safe cytotoxic preparation
• Trained nursing leadership in chemotherapy safety and oncologic emergencies

Consultant Medical Oncologist at Haroun Hospital, Beirut (2009-09 – 2023-04)

Delivered advanced systemic cancer therapy. Managed advanced/metastatic malignancies. Provided palliative and supportive oncology care. Mentored junior physicians and oncology nurses.

PhD Researcher – Molecular Oncology at University of Surrey (2014 – 2018)

Investigated molecular mechanisms of anticancer compounds focusing on MAPK/ERK and PI3K/AKT pathway inhibition.

• Thesis: In vitro and in vivo anticancer effects of β-2-himachalen-6-ol
• Demonstrated apoptosis induction mechanisms
• Conducted in vitro and in vivo preclinical studies
• Generated multiple peer-reviewed publications

Researcher – Anticancer Drug Development at Lebanese American University (2013 – 2019)

Investigated molecular mechanisms of β-2-himachalen-6-ol. Contributed to translational oncology publications.

Clinical Researcher – Phase II Clinical Trial at Bitar Hospital, Lebanon (2009 – 2023)

Participated in development of Phase II trial in advanced/metastatic breast cancer. Investigated cholesterol-derived anticancer molecules. Contributed to oncology publications.

Academic Editor at Intech Open (2018 – 2023)

Supervised peer review of oncology manuscripts.

• Academic Editor: "Squamous Cell Carcinoma: Hallmark and Treatment Modalities"
• Author: "Treatment Strategies in Colorectal Cancer"

Lecturer – Internal Medicine & Oncology at Kursk State Medical University (2000 – 2001)

Taught undergraduate medical students. Recognized for academic excellence and student evaluations.

PhD in Oncology – University of Surrey (2018)

Certificate in Medical Oncology – Kursk State Medical University (2002)

MD – Kursk State Medical University (1998)

Pre-medical Studies – American University of Beirut